SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-08-023717
Filing Date
2008-04-10
Accepted
2008-04-10 17:00:52
Documents
1
Group Members
OAKTREE CAPITAL GROUP HOLDINGS GP, LLCOAKTREE CAPITAL GROUP HOLDINGS, L.P.OAKTREE CAPITAL GROUP, LLCOAKTREE CAPITAL I, L.P.OAKTREE FUND GP I, L.P.OAKTREE HOLDINGS, LLCOCM HOLDINGS I, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D/A a08-10301_1sc13da.htm SC 13D/A 224684
  Complete submission text file 0001104659-08-023717.txt   226892
Mailing Address 41 UNIVERSITY DRIVE NEWTON PA 18940
Business Address 41 UNIVERSITY DRIVE NEWTON PA 18940 2155797388
COLLAGENEX PHARMACEUTICALS INC (Subject) CIK: 0001012270 (see all company filings)

IRS No.: 521758016 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-47825 | Film No.: 08750520
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address C/O OAKTREE CAPITAL MANAGEMENT LLC 333 SOUTH GRAND 28TH FL LOS ANGELES CA 90071
Business Address C/O OAKTREE CAPITAL MANAGEMENT LLC 333 SOUTH GRAND 28TH FL LOS ANGELES CA 90071 2138306484
OCM PRINCIPAL OPPORTUNITIES FUND L P (Filed by) CIK: 0001020638 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A